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OBJECTIVES We sought to demonstrate the mode of spontaneous onset of ventricular fibrillation (VF) in
patients with Brugada syndrome.
BACKGROUND The electrophysiologic mechanisms of VF in Brugada syndrome have not been fully
investigated.
METHODS Nineteen patients (all male, mean age 47 6 12 years) with Brugada syndrome were treated
with an implantable cardioverter defibrillator (ICD). The implanted devices were capable of
storing electrograms during an arrhythmic event. We investigated the mode of spontaneous
onset of VF according to the electrocardiographic features during the episode of VF, which
were obtained from stored electrograms of ICDs and/or electrocardiographic (ECG)
monitoring.
RESULTS During a follow-up of 34.7 6 19.4 months (range 14 to 81 months), 46 episodes of
spontaneous VF attacks were documented in 7/19 (37%) patients. The event-free period
between ICD implantation and the first spontaneous occurrence of VF was 14.6 6 12.1
months (range 3.7 to 27.4 months). We investigated 33/46 episodes of VF, for which
electrocardiographic features (10 to 20 s before and during VF) were obtained from ICDs
and/or ECG monitoring in five patients. A total of 22/33 episodes of VF were preceded by
premature ventricular contractions (PVCs), which were almost identical to the initiating
PVCs of VF. Furthermore, in three patients who had multiple VF episodes, VF attacks were
always initiated by the same respective PVC. The coupling interval of the initiating PVCs of
VF was 388 6 28 ms.
CONCLUSIONS Spontaneous episodes of VF in patients with Brugada syndrome were triggered by specific
PVCs. These findings may provide important insights into the pathophysiological mecha-
nisms causing VF in Brugada syndrome. (J Am Coll Cardiol 2000;36:1646–53) © 2000 by
the American College of Cardiology
Ventricular fibrillation (VF) is a major cause of out-of-
hospital sudden death. As there is no demonstrable struc-
tural heart disease in 5% to 10% of these patients, this form
of VF has been recognized as idiopathic VF (1–4). Recent
interest has focused on one distinctive subgroup of idio-
pathic VF, so-called Brugada syndrome (5). This intriguing
syndrome is characterized by right bundle branch block,
normal QT interval, persistent ST segment elevation in
precordial leads V1 to V2 or to V3 and sudden death.
Owing to the high recurrence rate of VF in this syndrome
(18% to 37% during a follow-up of one to three years), an
implantable cardioverter defibrillator (ICD) is the generally
accepted mode of therapy, improving the long-term prog-
nosis in these patients (1,6–9). However, the electrophysi-
ologic mechanisms of VF in Brugada syndrome have not yet
been fully investigated.
Analysis of electrocardiographic manifestations during an
episode of ventricular arrhythmia is an effective method of
clarifying the episode’s mechanism. We investigated the
mode of spontaneous onset of VF in patients with Brugada
syndrome using ICDs, which provide extensive storage of
endocardial electrograms during episodes of arrhythmia.
METHODS
Patients. We studied 19 patients (all male; mean age 47 6
12 years) with Brugada syndrome who underwent implan-
tation of an ICD. Written informed consent to participate
in this study was obtained from all patients. The ICDs were
implanted between July 1992 and February 1998. Clinical
follow-up was obtained until March 1999. The presence of
structural heart disease or coronary artery disease was
excluded in all patients by noninvasive and invasive tests,
such as normal laboratory tests, including enzymatic and
electrolytic profile; no significant stenosis and no spasm
inducible in coronary angiography; normal right and left
ventricular size and function, as assessed by echocardiogra-
phy, nuclear scintigraphy, and ventriculography of both
ventricles; and normal right ventricular endomyocardial
biopsy findings.
All patients had right bundle branch block pattern and
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persistent ST segment elevation in right precordial electro-
cardiographic (ECG) leads (Fig. 1). The PR, QT and QTc
intervals were within normal limits. Episodes of VF or
sudden death were documented before ICD implantation.
During electrophysiologic study, VF or polymorphic ven-
tricular tachycardia was induced by programmed electrical
stimulation in all patients. In Holter ECG, all patients had
few PVCs outside of the VF episodes.
In 12 of the 19 patients in this study, we have recently
reported the circadian pattern of the development of ven-
tricular fibrillation in Brugada syndrome (10).
The device. Six different types of ICDs were implanted in
the study patients: the Ventak P (n 5 3), Ventak PRX-II
(n 5 3) and Ventak Mini (n 5 2) (Cardiac Pacemaker, Inc.,
St. Paul, Minnesota), and the PCD (n 5 1), Jewel Plus (n 5
2) and Micro Jewel (n 5 8) (Medtronic, Inc., Minneapolis,
Minnesota). All ICDs except for the Ventak P and PCD
have extensive retrievable data-logging capabilities, includ-
ing storage of the time, date, pre- and post-therapy R-R
intervals, tachycardia cycle length and the ICD response to
tachycardia detection. The Ventak PRX-II, Ventak Mini
and Micro Jewel are capable of storing electrograms 10 to
20 s before, during and after an arrhythmic event. In the
Ventak PRX-II and Ventak Mini, the stored electrograms
are recorded between the distal spring electrode in the right
ventricle and the proximal spring electrode in the high right
atrium to the superior vena cava. The Micro Jewel was
programmed to record the electrograms between the distal
spring electrode in the right ventricle and the precordial
Can. The stored electrograms obtained from these systems
provide a more global visualization of myocardial activity.
The Ventak P is able only to confirm the number of shocks,
and cannot provide the time or date of the shock or
electrograms during VF. However, because the total num-
ber of shocks identified by the ICD was compatible with the
patient’s memory of symptoms and/or the witnessed events,
reliable rough information concerning the time and date of
the VF episodes was considered to be available.
We investigated the mode of spontaneous onset of VF
according to the electrocardiographic features before and
during VF, which were obtained from stored electrograms
of ICDs and/or ECG monitoring. “Preceding PVCs” was
defined as PVCs recorded shortly before the episode of VF.
“Initiating PVCs” was defined as the first complex of the VF
episode.
Statistical analysis. The event-free survival curve was ob-
tained using the Kaplan–Meier method. Quantitative data
are expressed as mean 6 SD.
RESULTS
During a follow-up of 34.7 6 19.4 months (range 14 to 81
months), all patients survived, and 46 episodes of sponta-
neous VF attacks were detected in 7 (37%) of the 19 patients
(1 to 23 episodes per patient) (Fig. 2). At the time of VF
detection, two patients were on beta-blocker to prevent
inappropriate shocks during supraventricular tachycardia.
The remaining patients did not take any antiarrhythmic
drug during the follow-up period. The event-free period
between ICD implantation and the first spontaneous occur-
rence of VF was 14.6 6 12.1 months (range, 3.7 to 27.4
months). Follow-up data of the patients with VF recurrence
after ICD implantation are shown in Table 1. In 43 of the
46 episodes of VF, defibrillation was successful on the first
shock; the second shock was necessary in the remaining
Abbreviations and Acronyms
ECG 5 electrocardiogram
ICD 5 implantable cardioverter defibrillator
PVC 5 premature ventricular contraction
VF 5 ventricular fibrillation
Figure 1. Twelve-lead electrocardiogram of Patient 4 with Brugada syndrome during sinus rhythm. An incomplete right bundle branch block and ST
segment elevation with a coved type in leads V1 and V2 were observed.
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three episodes. Electrocardiographic features obtained from
stored electrograms of ICDs and/or ECG monitoring were
available for 33 of the 46 episodes of VF (“documented”
episodes) in 5 patients. In Patient 5, in whom a Ventak P
was implanted, we were able to document electrocardio-
graphic manifestations during VF on ECG monitoring,
because he had a VF attack during his stay in our hospital.
In Patients 6 and 7, we were only able to analyze the date
and number of VF attacks due to limited memory function
of the late-generation ICD.
Mode of onset of VF.
1. Before the onset of VF, frequent preceding PVCs
were recorded in 22 of the 33 VF episodes (Fig. 3 and
4). In all these events, the morphology of the preced-
ing PVCs was almost identical (according to the
stored electrogram) to the initiating PVCs of VF.
2. Multiple VF episodes were stored in the devices of
three patients (Patients 1–3). Analysis of these events
revealed that different VF episodes in the same pa-
tients were initiated by PVCs of similar morphology
(Fig. 5).
Although no preceding PVC was observed in the
remaining 11 VF episodes, the morphology of initiat-
ing PVC was similar to that of preceding and initiat-
ing PVCs during different VF episodes (Fig. 6).
3. Three patients (Patients 1–3) underwent implantation
of the same ICD systems (Ventak PRX-II combined
with Endotak lead). Thus, we were able to compare
the morphology of the PVCs initiating VF in different
patients (Fig. 3). The morphology of PVCs in Patient
1 was strikingly similar to that of the PVCs of Patient
3. This finding indicates that the initiating PVC
originated from the particular common ventricular
focus in these patients.
4. According to the R-R intervals stored for 39 VF
episodes in 6 patients, the PVCs initiating all VF
episodes arose from the terminal part of the T wave:
the coupling interval of the initiating PVC was 388 6
28 ms (range 336 to 453 ms) and the QT interval was
normal. Of note, a long-short sequence initiated VF in
only 1 patient (Patient 1) and in only 25% (5 of 21) of
his VF episodes. Thus, pause-dependent arrhythmias
were rare in VF episodes in Brugada syndrome.
DISCUSSION
In this study we demonstrated that (a) many spontaneous
episodes of VF in patients with Brugada syndrome were
preceded by frequent PVCs, (b) preceding and initiating
PVCs of a single and different VF episodes in the same
patient showed the same pattern of QRS morphology and
(c) the QRS patterns of PVCs in two different patients
(Patients 1 and 3) were very similar to each other.
The relationship of PVCs and VF. Although, in patients
with Brugada syndrome, very few PVCs were observed on
Holter monitoring at the remote phase of VF episodes,
these tended to occur more frequently before the onset of
VF. This finding suggests that there is a close relationship
between PVCs and the occurrence of VF. Furthermore,
another clinical study demonstrated progressive ST segment
elevation in right precordial leads immediately before VF
onset (11). Therefore, it is strongly suggested that the series
of electrocardiographic phenomena in this syndrome (ST
elevation, frequent PVC and VF) derives from a common
electrophysiologic mechanism. Antzelevitch et al. induced
Figure 2. Event-free survival rate after ICD implantation for all 19
patients (Kaplan–Meier method). The number at the bottom of graph
indicates the number of patients at risk at each time point.
Table 1. Follow-Up Data of the Patients With VF Recurrence After ICD Implantation
Patient
no. ICD generator
Follow-up
Period
(Months)
Total VF
Detection
Number
(Times)
EGM and/or ECG
Documentation
at the VF
onset (Times)
First VF
Detection
Interval
(Months)
1. Ventak PRX-II 59.2 23 21 3.7
2. Ventak PRX-II 61.3 5 5 22.5
3. Ventak PRX-II 60.2 5 5 27.4
4. Micro Jewel 24.4 3 1 8.1
5. Ventak P 33.6 5 1 11.0
6. Jewel Plus 43.9 4 0 9.8
7. Ventak P 31.9 1 0 20.1
ECG 5 electrocardiogram; EGM 5 stored electrogram; ICD 5 implantable cardioverter defibrillator; VF 5 ventricular
fibrillation.
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ST segment elevation similar to that in Brugada syndrome
by producing a transmural voltage gradient during repolar-
ization, which was provoked by a loss of action potential
dome in epicardium but not endocardium. This sole elec-
trophysiologic mechanism properly accounts for the ST
segment elevation, the PVC (phase 2 reentry) and the
substrate for VF (increased dispersion of repolarization) in
Brugada syndrome (12–14).
The identity of the PVCs. Preceding and initiating PVC
of VF episodes in our patients showed a similar pattern of
QRS morphology, which suggests that the PVCs originat-
ing from the peculiar ventricular sites may relate to electro-
physiologic mechanism of VF in Brugada syndrome.
Because the stored electrograms in the present study were
obtained from endocardial sites and were single-channel
recordings, we cannot assess the origin of the PVCs exactly.
However, several clinical and experimental studies suggest
that the specific ventricular sites (e.g., right ventricular free
wall) can be the most possible foci for triggering PVC
(11,15–20). The ST segment elevation in leads V1 to V3
suggests electrophysiologic abnormality in the right ventric-
ular free wall, because the area may influence the right
precordial ECG leads. If marked shortening of action
potential duration is the mechanism of ST elevation, PVC
firing from the area with shorter action potential duration
owing to phase 2 reentry is most likely to induce VF (21,22).
The coupling interval of the initiating PVC. PVC firing
at the most vulnerable period of the ventricle (near the peak
of T wave) may lead to the genesis of reentry. Actually, in
several clinical settings, short-coupled PVC (about 250 to
300 ms) has been demonstrated to occur before episodes of
VF or polymorphic ventricular tachycardia (23,24). How-
ever, the coupling interval of the first PVC of VF in the
present study was 388 ms, and therefore, its onset was close
to the end of T wave. Kasanuki et al. (11) also reported a
.300 ms coupling interval of the first PVC during VF
episode in Brugada syndrome. During the electropysiologic
study at the remote phase of the VF episode, multiple
extrastimuli with very short coupling intervals (,200 ms)
were found to be necessary to induce VF in Brugada
syndrome. However, at the spontaneous onset of VF, it is
obvious that only single- and longer (.300 ms) coupled
PVCs are able to provoke VF. These facts indicate the
importance of the site-specificity of the PVC focus and the
acutely increased vulnerability of the ventricle before spon-
taneous VF episodes.
Post-extrasystolic pause generated by PVCs may be
associated with the ST segment elevation and the develop-
ment of ventricular arrhythmia. Several clinical studies
reported that the longer preceding cycles after a PVC
augmented the J wave and ST segment elevation (25,26).
These findings are consistent with the experimental data
showing that premature stimulation restored the loss of the
action potential dome due to the slow reactivation kinetics
of Ito (12,14). Although the long-short initiating sequence
may enhance the electrophysiologic mechanism of VF in
Brugada syndrome, pause-dependent PVC and/or first beat
of VF was demonstrated in only one patient.
Study limitations. It has been considered that increased
vagal activity is related to the development of VF in Brugada
syndrome (11). Analysis of heart rate variability using stored
electrograms and/or R-R logs in ICD may help to prove a
role of vagal activity. However, the data stored in the ICDs
were too short to analyze the heart rate variability before the
onset of VF. Moreover, because intracardiac electrograms
were recorded by digital signal and single endocardial lead
systems, we could not precisely investigate the coupling
interval, PVC morphology or level of ST segment. In this
study, although VF attacks were detected in 7 patients,
electrocardiograms were available for only 5 (26%) of the 19
Figure 4. Stored intracardiac electrograms from Patient 4, with Micro Jewel II and ECG monitoring of Patient 5 with Ventak P at the initiation of VF.
As in Figure 2, all VF episodes were preceded by the PVCs (asterisk), which were almost identical to the initiating beats of VF.
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patients. In Patients 6 and 7, we were unable to obtain the
stored electrogram of ICD because of limited ICD memory
function, and ECG monitoring was impossible because the
VF episodes occurred out of hospital. Therefore, all VF
events in the present patients were not fully investigated,
and several exceptions might be present.
Clinical implications. Patients with Brugada syndrome
are at high risk of sudden death. At the present time, ICD
is the generally accepted mode of therapy. However, no
preventive therapy for VF in Brugada syndrome has yet
been established. Because VF appears to be initiated by a
particular PVC, it is possible that VF could be avoided by
(radiofrequency) ablation targeting the initiating PVCs
(27,28).
Conclusions. Spontaneous episodes of VF in patients with
Brugada syndrome were triggered by specific PVCs. These
findings may provide important insights into the patho-
physiological mechanisms causing VF in Brugada syn-
drome.
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